Abstract
Objective
To present a snapshot of 10 y of pediatric research, with a focus on trials with at least one enrolling site in India.
Methods
The study included all interventional trials registered at ClinicalTrials.gov from January 2006 through December 2015, enrolling patients aged 0 to 18 y. The database for Aggregate Analysis of ClinicalTrials.gov (AACT) was the data source used.
Results
Nine thousand, six hundred forty-eight pediatric clinical studies were identified. Of these, 193 had at least one enrolling site in India. The primary purpose for most of these trials was treatment (n = 92) and prevention (n = 65) coupled with an efficacy and/or safety endpoint (n = 158). Infant and toddlers were eligible for enrollment in the majority of trials (97%) while neonates only in 22% of trials. The rate of early termination or withdrawal was 5%. The most commonly studied conditions were bacterial infections, viruses, digestive and mental diseases. Overall, communicable diseases (n = 75) and major non-communicable diseases (n = 72) were equally investigated.
Conclusions
The most commonly studied therapeutic areas in trials enrolling from India and registered in ClinicalTrials.gov were appropriate for India public health needs and patients were not enrolled into studies inappropriately from this perspective.
Similar content being viewed by others
References
Joseph PD, Craig JC, Tong A, Caldwell PH. Researchers’, regulators’, and sponsors’ views on pediatric clinical trials: a multinational study. Pediatrics. 2016;138:pii:e20161171.
MacLeod SM, Knoppert DC, Stanton-Jean M, Avard D. Pediatric clinical drug trials in low-income countries: key ethical issues. Paediatr Drugs. 2015;17:83–90.
Medical Research Council (MRC). MRC Ethics Guide: Medical Research Involving Children. London: Medical Reserch Council; 2004.
Grimsrud KN, Sherwin CM, Constance JE, et al. Special population considerations and regulatory affairs for clinical research. Clin Res Regul Aff. 2015;32:47–56.
Bavdekar SB. Pediatric clinical trials. Perspect Clin Res. 2013;4:89–99.
Piantadosi S. Clinical trials. Chicester: Wiley-Blackwell; 2005.
Turner MA, Catapano M, Hirschfeld S, Giaquinto C. Global research in paediatric drug development: the impact of evolving regulations. Adv Drug Deliv Rev. 2014;73:2–13.
Indian Council of Medical Research (ICMR). National Ethics Guidelines for Biomedical Research Involving Children. New Delhi: Indian Council of Medical Research; 2017. Available at:www.icmr.nic.in/sites/default/files/guidelines/National_Ethical_Guidelines_for_Biomedical_Research_Involving_Children_0.pdf. Accessed 20 Nov 2018.
Indian Council of Medical Research (ICMR). Ethical Guidelines for Biomedical Research on Human Subjects. 2006.
Tasneem A, Aberle L, Ananth H, et al. The database for aggregate analysis of ClinicalTrials.gov (AACT) and subsequent regrouping by clinical specialty. PLoS One. 2012;7:e33677.
Breiman L. Out-of-bag estimation. ftp. stat. berkeley. edu/pub/users/breiman. OOBestimation ps. 1996;199(6).
Pasquali SK, Lam WK, Chiswell K, Kemper AR, Li JS. Status of the pediatric clinical trials enterprise: an analysis of the US ClinicalTrials.gov registry. Pediatrics. 2012;130:e1269–77.
Siegel KR, Patel SA, Ali MK. Non-communicable diseases in South Asia: contemporary perspectives. Br Med Bull. 2014;111:31–44.
Williams K, Thomson D, Seto I, et al. Standard 6: age groups for pediatric trials. Pediatrics. 2012;129:S153–60.
Kshirsagar N, Swaminathan S, Jog P, et al. Regulatory and ethical issues in pediatric clinical research: recommendations from a panel discussion. J Clin Pharmacol. 2017;57:943–6.
Bourgeois FT, Olson KL, Ioannidis JP, Mandl KD. Association between pediatric clinical trials and global burden of disease. Pediatrics. 2014;133:78–87.
Global Burden of Disease Pediatrics C, Kyu HH, Pinho C, Wagner JA, et al. Global and national burden of diseases and injuries among children and adolescents between 1990 and 2013: findings from the global burden of disease 2013 study. JAMA Pediatr. 2016;170:267–87.
Bansal CP. Improving child health in India, how to set an agenda? Indian Pediatr. 2013;50:17–9.
Srivastava RN. Right to health for children. Indian Pediatr. 2015;52:15–8.
Viergever RF, Li K. Trends in global clinical trial registration: an analysis of numbers of registered clinical trials in different parts of the world from 2004 to 2013. BMJ Open. 2015;5:e008932.
Baldi I, Lanera C, Berchialla P, Gregori D. Early termination of cardiovascular trials as a consequence of poor accrual: analysis of ClinicalTrials.gov 2006–2015. BMJ Open. 2017;7:e013482.
Dunne J, Murphy MD, Rodriguez WJ. The globalization of pediatric clinical trials. Pediatrics. 2012;130:e1583–91.
Author information
Authors and Affiliations
Contributions
IB designed the study; IB and GL wrote the manuscript; DA performed the statistical analysis; MR and RIC critically revised the manuscript and contributed to the discussion. All authors contributed to results interpretation, read and approved the final manuscript. IB will act as guarantor for this paper.
Corresponding author
Ethics declarations
Conflict of Interest
None.
Source of Funding
None.
Rights and permissions
About this article
Cite this article
Lorenzoni, G., Comoretto, R.I., Ruffolo, M. et al. Pediatric Trials Run in India: An Analysis of Clinical Trials.gov 2006–2015. Indian J Pediatr 86 (Suppl 1), 10–14 (2019). https://doi.org/10.1007/s12098-018-2825-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-018-2825-7